Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, June 19, 2026
🇺🇸 FDA

Kidney Disease News

🇺🇸 FDA

FDA breaking news and regulatory updates for BD, investors, and analysts

Showing 1–2 of 2 articles

High impact NewsMay 4, 2026

Akebia Therapeutics Vadadustat Shows Significant Mortality Reduction in New Kidney Disease Analysis

2 min

Dr. Natalie Hughes
Critical impact NewsApr 15, 2026

FDA Approves FILSPARI (Sparsentan) for FSGS: First Treatment for Rare Kidney Disease

FDA · Nephrology - Focal Segmental Glomerulosclerosis (FSGS) · 4 min

Dr. Sarah Mitchell

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.